Da: Ammareal, Morangis, Francia
EUR 3,50
Quantità: 1 disponibili
Aggiungi al carrelloSoftcover. Condizione: Bon. Ancien livre de bibliothèque avec équipements. Edition 1985. Ammareal reverse jusqu'à 15% du prix net de cet article à des organisations caritatives. ENGLISH DESCRIPTION Book Condition: Used, Good. Former library book. Edition 1985. Ammareal gives back up to 15% of this item's net price to charity organizations.
Condizione: As New. Unread book in perfect condition.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 60,28
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Da: Chiron Media, Wallingford, Regno Unito
EUR 56,57
Quantità: 10 disponibili
Aggiungi al carrelloPF. Condizione: New.
Condizione: New.
Da: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
EUR 69,24
Quantità: 15 disponibili
Aggiungi al carrelloCondizione: New. Series: Agents and Actions, Supplements. Num Pages: 203 pages, 8 black & white illustrations, biography. BIC Classification: YQS. Category: (G) General (US: Trade). Dimension: 244 x 170 x 11. Weight in Grams: 545. . 1985. Softcover reprint of the original 1st ed. 1985. Paperback. . . . .
Da: Revaluation Books, Exeter, Regno Unito
EUR 78,44
Quantità: 2 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. 208 pages. German language. 9.61x6.70x0.44 inches. In Stock.
Da: Kennys Bookstore, Olney, MD, U.S.A.
Condizione: New. Series: Agents and Actions, Supplements. Num Pages: 203 pages, 8 black & white illustrations, biography. BIC Classification: YQS. Category: (G) General (US: Trade). Dimension: 244 x 170 x 11. Weight in Grams: 545. . 1985. Softcover reprint of the original 1st ed. 1985. Paperback. . . . . Books ship from the US and Ireland.
Lingua: Inglese
Editore: Birkhäuser Basel, Springer Basel, 1985
ISBN 10: 3764317507 ISBN 13: 9783764317508
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 53,49
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - Non-steroidal anti-inflammatory drugs (NSAIDs) are one of the most commonly prescribed groups of drugs in the community. This reflects the high frequency of rheumatic complaints but may in part be due to the relative non efficacy of these drugs. Since the introduction of ibuprofen, the first new NSAID to compete with aspirin, phenylbutazone and indomethacin, there has been a proliferation of new NSAIDs of differing chemical classes but an apparent similar spectrum of action. Despite the fact that these drugs are thought to work by an apparent common mechanism of action (suppression of prostaglandin synthetase activity) continued development of these drugs occurs. There exists at present a conflict between the pharmaceutical industry with its attempts to introduce new NSAIDs and drug regulatory authorities who are generally not convinced of the need for additional drugs of_ this class. The practising clinician regards a variety of NSAIDs as necessary to enable pain relief to be optimised.with minimal adverse effects. With respect to the dilemma of how many NSAIDs are really necessary surprisingly little convincing data is available to assist in resolving this issue. It was therefore decided to hold a satellite meeting to the XVIth International League Against Rheumatism Conference in May 1985.
Da: moluna, Greven, Germania
EUR 48,37
Quantità: Più di 20 disponibili
Aggiungi al carrelloKartoniert / Broschiert. Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Non-steroidal anti-inflammatory drugs (NSAIDs) are one of the most commonly prescribed groups of drugs in the community. This reflects the high frequency of rheumatic complaints but may in part be due to the relative non efficacy of these drugs. Since the i.
Lingua: Inglese
Editore: Springer, Basel, Birkhäuser Basel, Birkhäuser Jan 1985, 1985
ISBN 10: 3764317507 ISBN 13: 9783764317508
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
EUR 85,59
Quantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Non-steroidal anti-inflammatory drugs (NSAIDs) are one of the most commonly prescribed groups of drugs in the community. This reflects the high frequency of rheumatic complaints but may in part be due to the relative non efficacy of these drugs. Since the introduction of ibuprofen, the first new NSAID to compete with aspirin, phenylbutazone and indomethacin, there has been a proliferation of new NSAIDs of differing chemical classes but an apparent similar spectrum of action. Despite the fact that these drugs are thought to work by an apparent common mechanism of action (suppression of prostaglandin synthetase activity) continued development of these drugs occurs. There exists at present a conflict between the pharmaceutical industry with its attempts to introduce new NSAIDs and drug regulatory authorities who are generally not convinced of the need for additional drugs of_ this class. The practising clinician regards a variety of NSAIDs as necessary to enable pain relief to be optimised.with minimal adverse effects. With respect to the dilemma of how many NSAIDs are really necessary surprisingly little convincing data is available to assist in resolving this issue. It was therefore decided to hold a satellite meeting to the XVIth International League Against Rheumatism Conference in May 1985. 203 pp. Englisch.
Lingua: Inglese
Editore: Birkhäuser, Birkhäuser Jan 1985, 1985
ISBN 10: 3764317507 ISBN 13: 9783764317508
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germania
EUR 53,49
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Non-steroidal anti-inflammatory drugs (NSAIDs) are one of the most commonly prescribed groups of drugs in the community. This reflects the high frequency of rheumatic complaints but may in part be due to the relative non efficacy of these drugs. Since the introduction of ibuprofen, the first new NSAID to compete with aspirin, phenylbutazone and indomethacin, there has been a proliferation of new NSAIDs of differing chemical classes but an apparent similar spectrum of action. Despite the fact that these drugs are thought to work by an apparent common mechanism of action (suppression of prostaglandin synthetase activity) continued development of these drugs occurs. There exists at present a conflict between the pharmaceutical industry with its attempts to introduce new NSAIDs and drug regulatory authorities who are generally not convinced of the need for additional drugs of_ this class. The practising clinician regards a variety of NSAIDs as necessary to enable pain relief to be optimised.with minimal adverse effects. With respect to the dilemma of how many NSAIDs are really necessary surprisingly little convincing data is available to assist in resolving this issue. It was therefore decided to hold a satellite meeting to the XVIth International League Against Rheumatism Conference in May 1985.Springer Nature c/o IBS, Benzstrasse 21, 48619 Heek 208 pp. Englisch.